LBF20207PG41: Difference between revisions

No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 6: Line 6:
|LipidBank=XPR1772
|LipidBank=XPR1772
|LipidMaps=LMFA03010102
|LipidMaps=LMFA03010102
|SysName=(9alpha,15R) -Dihydroxy-11-oxo-prosta- (5-trans,13-trans) -dien-1-oic acid
|SysName=(9S,15R) -Dihydroxy-11-oxo- (cis-5,trans-13) -prostadienoic acid
|Common Name=&&15(R)- Prostaglandin D_2&&(9alpha,15R) -Dihydroxy-11-oxo-prosta- (5E,13E) -dien-1-oic acid&&
|Common Name=&&15(R) - Prostaglandin D_2&&(9S,15R) -Dihydroxy-11-oxo- (5Z,13E) -prostadienoic acid&&(9alpha,15R) -Dihydroxy-11-oxo-prosta- (5Z,13E) -dien-1-oic acid&&


|Source=
|Source=

Latest revision as of 03:13, 2 November 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



15(R) - Prostaglandin D2
LBF20207PG41.png
Structural Information
(9S,15R) -Dihydroxy-11-oxo- (cis-5,trans-13) -prostadienoic acid
  • 15(R) - Prostaglandin D2
  • (9S,15R) -Dihydroxy-11-oxo- (5Z,13E) -prostadienoic acid
  • (9α,15R) -Dihydroxy-11-oxo-prosta- (5Z,13E) -dien-1-oic acid
Formula C20H32O5
Exact Mass 352.224974134
Average Mass 352.46508
SMILES C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC
Physicochemical Information
15(R)-PGD2 is reported to have potent agonistic effect to the DP2 receptor 5 time higher than PGD2. Giles_H et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG41 See above. Giles_H et al. 1989